Plasmolipin regulates basolateral-to-apical transcytosis of ICAM-1 and leukocyte adhesion in polarized hepatic epithelial cells.


Journal

Cellular and molecular life sciences : CMLS
ISSN: 1420-9071
Titre abrégé: Cell Mol Life Sci
Pays: Switzerland
ID NLM: 9705402

Informations de publication

Date de publication:
09 Jan 2022
Historique:
received: 27 04 2021
accepted: 03 12 2021
revised: 02 12 2021
entrez: 9 1 2022
pubmed: 10 1 2022
medline: 19 1 2022
Statut: epublish

Résumé

Apical localization of Intercellular Adhesion Receptor (ICAM)-1 regulates the adhesion and guidance of leukocytes across polarized epithelial barriers. Here, we investigate the molecular mechanisms that determine ICAM-1 localization into apical membrane domains of polarized hepatic epithelial cells, and their effect on lymphocyte-hepatic epithelial cell interaction. We had previously shown that segregation of ICAM-1 into apical membrane domains, which form bile canaliculi and bile ducts in hepatic epithelial cells, requires basolateral-to-apical transcytosis. Searching for protein machinery potentially involved in ICAM-1 polarization we found that the SNARE-associated protein plasmolipin (PLLP) is expressed in the subapical compartment of hepatic epithelial cells in vitro and in vivo. BioID analysis of ICAM-1 revealed proximal interaction between this adhesion receptor and PLLP. ICAM-1 colocalized and interacted with PLLP during the transcytosis of the receptor. PLLP gene editing and silencing increased the basolateral localization and reduced the apical confinement of ICAM-1 without affecting apicobasal polarity of hepatic epithelial cells, indicating that ICAM-1 transcytosis is specifically impaired in the absence of PLLP. Importantly, PLLP depletion was sufficient to increase T-cell adhesion to hepatic epithelial cells. Such an increase depended on the epithelial cell polarity and ICAM-1 expression, showing that the epithelial transcytotic machinery regulates the adhesion of lymphocytes to polarized epithelial cells. Our findings strongly suggest that the polarized intracellular transport of adhesion receptors constitutes a new regulatory layer of the epithelial inflammatory response.

Identifiants

pubmed: 34999972
doi: 10.1007/s00018-021-04095-z
pii: 10.1007/s00018-021-04095-z
pmc: PMC8743267
doi:

Substances chimiques

ICAM1 protein, human 0
Myelin and Lymphocyte-Associated Proteolipid Proteins 0
PLLP protein, human 0
Intercellular Adhesion Molecule-1 126547-89-5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

61

Subventions

Organisme : Agencia Estatal de Investigación
ID : SAF2017-88187
Organisme : Agencia Estatal de Investigación
ID : PID2020-119881RB-I00
Organisme : Comunidad de Madrid
ID : S2017/BMD-3817 TomoXliver

Informations de copyright

© 2022. The Author(s).

Références

Nucleic Acids Res. 2015 Aug 18;43(14):6787-98
pubmed: 26117540
Science. 2015 Jan 23;347(6220):1260419
pubmed: 25613900
Blood. 2002 Feb 1;99(3):978-84
pubmed: 11807002
J Biol Chem. 1997 Jul 18;272(29):18311-5
pubmed: 9218471
Cell Mol Life Sci. 2012 Sep;69(18):3079-99
pubmed: 22573182
Nat Protoc. 2007;2(10):2480-91
pubmed: 17947990
Nat Cell Biol. 2015 Mar;17(3):241-50
pubmed: 25706235
Mol Biol Cell. 2002 Jan;13(1):225-37
pubmed: 11809835
Mol Biol Cell. 2007 Oct;18(10):3978-92
pubmed: 17686995
J Cell Biol. 2016 May 9;213(3):385-402
pubmed: 27138256
Nat Cell Biol. 2006 Feb;8(2):113-23
pubmed: 16429128
J Cell Biol. 2017 Nov 6;216(11):3847-3859
pubmed: 28887437
Mucosal Immunol. 2014 Jul;7(4):905-15
pubmed: 24345805
Nature. 2011 Jun 29;475(7356):390-3
pubmed: 21716291
J Cell Sci. 2019 Oct 10;133(5):
pubmed: 31601617
Mol Med. 1996 Jul;2(4):489-505
pubmed: 8827719
Am J Pathol. 2019 Oct;189(10):1933-1944
pubmed: 31404540
Mol Biol Cell. 2008 Oct;19(10):4224-37
pubmed: 18685082
J Immunol. 1986 Aug 15;137(4):1270-4
pubmed: 3525675
Dev Cell. 2010 May 18;18(5):814-27
pubmed: 20493814
Trends Biochem Sci. 2002 Dec;27(12):599-601
pubmed: 12468223
Cell Mol Life Sci. 2019 Apr;76(7):1299-1317
pubmed: 30552441
Viruses. 2017 Apr 01;9(4):
pubmed: 28368306
Nat Rev Immunol. 2015 Nov;15(11):692-704
pubmed: 26471775
Dev Cell. 2006 Feb;10(2):223-32
pubmed: 16459301
Mol Biol Cell. 2013 Feb;24(4):483-94
pubmed: 23264465
J Exp Med. 2008 Dec 22;205(13):3201-13
pubmed: 19064697
J Leukoc Biol. 2020 Mar;107(3):393-408
pubmed: 31990103
J Cell Sci. 2004 May 1;117(Pt 11):2183-92
pubmed: 15126620
Mediators Inflamm. 2016;2016:7650260
pubmed: 26941485
Methods Mol Biol. 2003;228:223-30
pubmed: 12824556
J Drug Target. 2017 Nov - Dec;25(9-10):786-795
pubmed: 28665212
FASEB J. 2002 Aug;16(10):1257-9
pubmed: 12060669
Mol Syst Biol. 2016 Apr 04;12(4):862
pubmed: 27044256
Nat Cell Biol. 2020 Feb;22(2):213-224
pubmed: 31988382
J Cell Sci. 2011 Aug 1;124(Pt 15):2529-38
pubmed: 21750196
J Cell Biol. 2002 Oct 14;159(1):37-44
pubmed: 12370246
Science. 2005 Dec 2;310(5753):1492-5
pubmed: 16282525
J Cell Biol. 2012 Mar 19;196(6):801-10
pubmed: 22412018
Eur J Immunol. 1998 Nov;28(11):3675-84
pubmed: 9842910
J Neurochem. 2003 Jul;86(2):508-18
pubmed: 12871592
Mol Biol Cell. 2009 Aug;20(16):3751-62
pubmed: 19553470
J Cell Biol. 1996 Nov;135(4):913-24
pubmed: 8922376
Nat Protoc. 2013 Nov;8(11):2281-2308
pubmed: 24157548
Nat Rev Immunol. 2006 Dec;6(12):919-29
pubmed: 17124513
J Cell Biol. 1997 Apr 21;137(2):347-57
pubmed: 9128247
J Cell Sci. 2001 Nov;114(Pt 22):3957-65
pubmed: 11739628
J Cell Sci. 2015 Jul 1;128(13):2293-302
pubmed: 26002055
Cell Rep. 2014 Sep 25;8(6):1879-1893
pubmed: 25242329

Auteurs

Cristina Cacho-Navas (C)

Centro de Biología Molecular Severo Ochoa, Universidad Autónoma de Madrid, CSIC-UAM, Cantoblanco, 28049, Madrid, Spain.

Natalia Reglero-Real (N)

Centro de Biología Molecular Severo Ochoa, Universidad Autónoma de Madrid, CSIC-UAM, Cantoblanco, 28049, Madrid, Spain.
William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

Natalia Colás-Algora (N)

Centro de Biología Molecular Severo Ochoa, Universidad Autónoma de Madrid, CSIC-UAM, Cantoblanco, 28049, Madrid, Spain.

Susana Barroso (S)

Centro de Biología Molecular Severo Ochoa, Universidad Autónoma de Madrid, CSIC-UAM, Cantoblanco, 28049, Madrid, Spain.

Gema de Rivas (G)

Centro de Biología Molecular Severo Ochoa, Universidad Autónoma de Madrid, CSIC-UAM, Cantoblanco, 28049, Madrid, Spain.

Kostantinos Stamatakis (K)

Centro de Biología Molecular Severo Ochoa, Universidad Autónoma de Madrid, CSIC-UAM, Cantoblanco, 28049, Madrid, Spain.

Jorge Feito (J)

Servicio de Anatomía Patológica, Hospital Universitario de Salamanca, Salamanca, Spain.

Germán Andrés (G)

Centro de Biología Molecular Severo Ochoa, Universidad Autónoma de Madrid, CSIC-UAM, Cantoblanco, 28049, Madrid, Spain.

Manuel Fresno (M)

Centro de Biología Molecular Severo Ochoa, Universidad Autónoma de Madrid, CSIC-UAM, Cantoblanco, 28049, Madrid, Spain.

Leonor Kremer (L)

Department of Immunology and Oncology, Centro Nacional de Biotecnología, CNB-CSIC, Madrid, Spain.
Protein Tools Unit, Centro Nacional de Biotecnología, CNB-CSIC, Madrid, Spain.

Isabel Correas (I)

Centro de Biología Molecular Severo Ochoa, Universidad Autónoma de Madrid, CSIC-UAM, Cantoblanco, 28049, Madrid, Spain.

Miguel A Alonso (MA)

Centro de Biología Molecular Severo Ochoa, Universidad Autónoma de Madrid, CSIC-UAM, Cantoblanco, 28049, Madrid, Spain.

Jaime Millán (J)

Centro de Biología Molecular Severo Ochoa, Universidad Autónoma de Madrid, CSIC-UAM, Cantoblanco, 28049, Madrid, Spain. jmillan@cbm.csic.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH